Cardiomyopathy: pathogenesis and therapeutic interventions

Area of Science:

• Cardiology and Genetics
• Molecular and Cellular Biology
• Translational Medicine

Background:

• Cardiomyopathy encompasses myocardial diseases stemming from diverse etiologies, including genetic mutations and systemic disorders.
• Understanding the molecular and cellular mechanisms underlying cardiomyopathy is crucial for developing effective treatments.
• Current therapies include pharmaceuticals, mechanical support, and heart transplantation, with gene and cell therapies showing emerging potential.

Purpose of the Study:

• To provide an in-depth analysis of the pathogenesis of various cardiomyopathies.
• To highlight the molecular and cellular mechanisms involved in cardiomyopathy development and progression.
• To review current and emerging therapeutic interventions, with a focus on gene therapy.

Main Methods:

• Literature review of current research on cardiomyopathy pathogenesis.
• Analysis of molecular and cellular mechanisms contributing to disease development.
• Evaluation of existing and novel therapeutic strategies, including gene therapy.

Main Results:

• Diverse etiologies contribute to cardiomyopathy, involving genetic mutations, environmental factors, and metabolic disorders.
• Significant progress has been made in identifying genes associated with cardiomyopathies.
• Gene therapy, particularly approaches targeting causal genes, demonstrates considerable therapeutic promise.

Conclusions:

• Targeting specific causal genes offers a precise and potentially advantageous therapeutic strategy for cardiomyopathies.
• Advancements in gene and cell therapy are revolutionizing treatment options for heart muscle diseases.
• Continued research into pathogenesis and therapeutic interventions is vital for improving patient outcomes in cardiomyopathy.